Epigenome-wide association study for lifetime estrogen exposure identifies an epigenetic signature associated with breast cancer risk

Annelie Johansson(Imperial College London), James M. Flanagan(QIMR Berghofer Medical Research Institute), Véronique Chajès(Centre international de recherche sur le cancer), Laura Baglietto, Pierre‐Antoine Dugué(The University of Melbourne), Salvatore Panico(Federico II University Hospital), Dallas R. English, Graham G. Giles(The University of Melbourne), Michael E. Jones(Institute of Cancer Research), Claudia Agnoli(Fondazione IRCCS Istituto Nazionale dei Tumori), Vittorio Perduca(Délégation Paris 5), Anthony J. Swerdlow(Institute of Cancer Research), Srikant Ambatipudi(Sree Chitra Thirunal Institute for Medical Sciences and Technology), Cyrille Cuenin, Carlotta Sacerdote(Cancer Prevention Institute of California), Roger L. Milne(The University of Melbourne), Amalia Mattiello(University of Naples Federico II), Silvia Polidoro(Cancer Prevention Institute of California), ­Rosario ­Tumino(Azienda Usl 8 Arezzo), Isabelle Romieu(German Cancer Research Center), Francesca Fasanelli(University of Turin), Giovanna Masala(Piedmont Reference Center for Epidemiology and Cancer Prevention), Sara Grioni(Fondazione IRCCS Istituto Nazionale dei Tumori), Domenico Palli(Piedmont Reference Center for Epidemiology and Cancer Prevention), Olivia Fletcher(Breast Cancer Care), Nick Orr(United States Department of Health and Human Services), Katarzyna Tomczyk(Institute of Cancer Research), Zdenko Herceg(Centre international de recherche sur le cancer), Paolo Vineis(Imperial College London), Melissa C. Southey(The University of Melbourne), Gianluca Severi(Inserm), Minouk J. Schoemaker(Institute of Cancer Research), Maria Concetta Giurdanella(University of Ragusa), Nichola Johnson(Institute of Cancer Research)
Clinical Epigenetics
April 30, 2019
Cited by 35


Related Papers